Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy

MeSH terms

• AIDS-Related Opportunistic Infections / prevention & control*
• Adult
• Amphotericin B / therapeutic use
• Animals
• Antiprotozoal Agents / therapeutic use*
• Antiretroviral Therapy, Highly Active / statistics & numerical data*
• Chemoprevention
• Female
• HIV Infections / drug therapy*
• Humans
• Leishmania infantum
• Leishmaniasis, Visceral / parasitology
• Leishmaniasis, Visceral / prevention & control*
• Liposomes / therapeutic use
• Male
• Meglumine / therapeutic use
• Meglumine Antimoniate
• Middle Aged
• Organometallic Compounds / therapeutic use
• Recurrence
• Treatment Outcome